AP PHARMA INC COM STK - 00202J203
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VHCP Management, LLC | History | New | 21,914,700 | 9,862 | 5.31% | — | 1 | +21,914,700 | New | Q4 2013 | Feb 13, 2014 |
| Alyeska Investment Group, L.P. | History | New | 1,000,000 | 445 | 0.02% | — | 2 | +1,000,000 | New | Q4 2013 | Feb 14, 2014 |
| Geduld E E | History | New | 500,000 | 223 | 0.11% | — | 3 | +500,000 | New | Q4 2013 | Jan 23, 2014 |